Tower Research Capital LLC (TRC) - CYCLACEL PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CYCLACEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,275
-39.9%
3,591
-0.4%
0.00%
Q2 2023$2,123
+106050.0%
3,605
-1.0%
0.00%
Q1 2023$2
+100.0%
3,641
+63.0%
0.00%
Q4 2022$1
-99.9%
2,234
+156.5%
0.00%
Q3 2022$1,000
-83.3%
871
-84.0%
0.00%
Q2 2022$6,000
-40.0%
5,442
+62.1%
0.00%
Q1 2022$10,000
+900.0%
3,358
+1579.0%
0.00%
Q4 2021$1,0000.0%200
-14.2%
0.00%
Q2 2021$1,000
-75.0%
233
-62.7%
0.00%
Q1 2021$4,000
+300.0%
624
+670.4%
0.00%
Q4 2020$1,000810.00%
Other shareholders
CYCLACEL PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 250,000$166,7500.04%
McIlrath & Eck, LLC 26,342$17,5700.01%
Schonfeld Strategic Advisors LLC 770,400$513,8570.00%
Virtu Financial LLC 23,793$160.00%
ACADIAN ASSET MANAGEMENT LLC 363,367$2400.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 64,068$42,7330.00%
CONDOR CAPITAL MANAGEMENT 10,000$6,6700.00%
Point72 Asset Management, L.P. 230,000$153,4100.00%
Ergoteles LLC 25,976$17,3260.00%
BlackRock Inc. 4,697$3,1320.00%
View complete list of CYCLACEL PHARMACEUTICALS INC shareholders